Loading insider details...
Beta
Latest Form 4 (Jan 12, 2026): Grant/Award of 350,000 TNGX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jan 12, 2026 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 350,000 | n/a |
| Nov 4, 2025 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 150,000 | n/a |
| Oct 9, 2025 | HOOKIPA Pharma Inc. (HOOK) | Sale | 25,172 | $20.7K |
| Jul 23, 2025 | HOOKIPA Pharma Inc. (HOOK) | Sale | 29,176 | $26.8K |
| Jun 9, 2025 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 6,250 | n/a |
| Jul 24, 2024 | HOOKIPA Pharma Inc. (HOOK) | Grant/Award | 108,695 | n/a |
| Jun 18, 2024 | HOOKIPA Pharma Inc. (HOOK) | Grant/Award | 49,000 | n/a |
| Jun 7, 2024 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 6,250 | n/a |
| Jun 9, 2023 | HOOKIPA Pharma Inc. (HOOK) | Grant/Award | 52,000 | n/a |
| Jun 9, 2023 | Tango Therapeutics, Inc. (TNGX) | Grant/Award | 5,000 | n/a |